Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Myocarditis IV: Nursing Management

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

Pericarditis III: Medical Management

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Emerging Trends in HIV-1 Sub-Subtype A6 in Belgium: Transmission Dynamics, Drug Resistance, and Subtyping Tool Evaluation.

Viruses·2026

Same author

The prognostic potential of fetal platelet count and viral load in prenatal cytomegalovirus infection: A retrospective cohort of 74 cases.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2026

Same author

Molecular Characterization of Parvovirus B19 in Pregnant Women During the 2024 Outbreak in Belgium.

Journal of medical virology·2025

Same author

Discrimination of primary and chronic cytomegalovirus infection based on humoral immune profiles in pregnancy.

The Journal of clinical investigation·2024

Same author

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.

BMC infectious diseases·2024

Same author

Long-term follow-up of a series of 24 congenital CMV-infected babies with false negative amniocentesis.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2024

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy

Published on: May 31, 2017

Fulminant myocarditis with dramatic response to corticoids.

Mickaël Moreels¹, Marie-Luce Delforge, Marc Renard

¹Department of Cardiology, Erasme University Hospital, Brussels, Belgium.

Acta Cardiologica

|March 24, 2010

Summary

This summary is machine-generated.

Fulminant myocarditis, a severe heart inflammation, can rapidly improve with corticoids. This case study shows prompt recovery in a patient with coxsackie B myocarditis and cardiogenic shock.

Related Experiment Videos

Last Updated: Jun 14, 2026

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy

Published on: May 31, 2017

Area of Science:

Cardiology
Infectious Diseases
Virology

Background:

Myocarditis is inflammation of the heart muscle, often caused by viral infections.
Coxsackie B virus is a common cause of viral myocarditis.
Fulminant myocarditis is a severe form characterized by rapid onset and high mortality.

Observation:

A 47-year-old healthy male presented with acute fulminant myocarditis.
The patient exhibited cardiogenic shock and significantly elevated N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) levels (82585 pg/ml).

Findings:

The patient experienced a dramatic and rapid improvement in his condition.
Treatment included dobutamine, standard care, and the administration of corticoids.

Implications:

Corticosteroid therapy may be a beneficial adjunctive treatment for severe coxsackie B viral myocarditis.
Early intervention with corticoids could improve outcomes in patients with fulminant myocarditis and cardiogenic shock.
Further research is warranted to establish the role of corticoids in managing fulminant myocarditis.